Press Release Details
Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market
Zone of potential insufficiency, where storage demand outstrips capacity, could be >25 zettabytes during 2030
Approximately 75% of all data stored to be ‘cold’ data, infrequently accessed ‘just in case’ it is needed
Data retention times are ‘indefinite,’ say key industry executives, never deleted
“We estimated the maximum production capabilities of current storage technologies (hard disk drive (HDD), solid state drive (SSD), tape) and concluded that potential demand at growth rates greater than 25% annually would exceed available supply of all enterprise-grade media,” said
Storage Capacity Today, Not Available Tomorrow: Zone of Potential Insufficiency
To date, enterprise storage capacity continues to be available, but the data shows that at current and projected growth rates, there likely will be zones of potential insufficiency where the predicted storage capacity cannot meet the storage demand.
The new white paper confirms that in 2019, 2020 and 2021, shipments of enterprise petabytes accelerated and grew by 35%, 33.6% and 48.3%, respectively. Estimates show that:
- Assuming a 35% annual growth rate in enterprise storage demand, during 2030 the zone of potential insufficiency could be 7.9 million petabytes (7.9 ZB).
- Assuming a 45% annual growth rate, the zone of potential insufficiency during 2030 could exceed 25 million petabytes (25 ZB).
Archival (cold) Data Volume could be ~75% of Installed Base of Enterprise Data, Remain Undeleted
Several industry interviews with industry executives responsible for more than 100-petabyte storage infrastructures in diverse markets said their data retention times were ‘indefinite.’ The author notes that, to date, we have seen little or no inclination of any kind in any corporation to delete any data, and there is no reason to believe this trend will change.
- Approximately 75% of the active installed base of enterprise storage could be ‘cold,’ mostly containing ‘Just In Case’ (JIC) or ‘Write Once Read Never’ (WORN) data.
- Cold storage data may never be accessed at all, nor in most cases will it ever be deleted
“DNA holds the promise of offering the magic three in storage: ultra-high-density, reasonable cost, and sustainability. We expect that new media will be needed to address the $7B+ of unmet storage demand projected in the years ahead, and we remain at the forefront of innovation in this market looking toward introducing the first commercial DNA data storage solution in the near future,” commented Emily M. Leproust, Ph.D., CEO and co-founder of
Expanding Power Requirements for Current Storage Solutions: Sustainability Considerations
The report notes new storage technologies must be more sustainable as the world’s appetite for data increases.
Dr. Leproust continued, “Today, the vast majority of enterprise data is stored on hard disk drives, which use a tremendous amount of power. As we prepare for the rapidly growing demand for storage, any new media must reduce the power consumption by one to two orders of magnitude. DNA is poised to do just that.”
To read the full Storage White Paper, please visit: https://www.twistbioscience.com/resources/white-paper/escalating-challenge-preserving-enterprise-data.
Legal Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained herein, including but not limited to projections of unmet demand for data storage, are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Twist Bioscience’s actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risks and uncertainties of the ability to attract new customers and retain and grow sales from existing customers; risks and uncertainties of rapidly changing technologies and extensive competition in synthetic biology could make the products
1 White paper jointly sponsored by Fujifilm and
SVP, Corporate Affairs